<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>Genesis Bioventures RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehen</description><link>http://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><image><url>http://images.finanzen.net/images/finanzen_net_neu.gif</url><title>Finanzen.net</title><link>http://www.finanzen.net</link></image><item><title>Abviva, Inc. (f/k/a Genesis Bioventures, Inc.) Announces Ticker Symbol Change to AVVA.OB</title><link>http://www.finanzen.net/nachricht/aktien/Abviva-Inc-f-k-a-Genesis-Bioventures-Inc-Announces-Ticker-Symbol-Change-to-AVVA-OB-265903</link><description>Abviva, Inc. (f/k/a Genesis Bioventures, Inc.) today announced that the 
      Company will begin trading under its new ticker symbol today – 
      (OTCBB:AVVA). The Company’s former ticker 
      symbol was GBIW.OB. The Company will continue to trade  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Abviva-Inc-f-k-a-Genesis-Bioventures-Inc-Announces-Ticker-Symbol-Change-to-AVVA-OB-265903</guid></item><item><title>Abviva Announces Letter of Intent to Acquire Prion Developmental Laboratories</title><link>http://www.finanzen.net/nachricht/aktien/Abviva-Announces-Letter-of-Intent-to-Acquire-Prion-Developmental-Laboratories-263700</link><description>Abviva, Inc. (f/k/a Genesis Bioventures: OTCBB:GBIW) today announced 
      that it has entered into a Letter of Intent with the Receiver for 
      Efoora, Inc. appointed by the United States District Court For The 
      Northern District of Illinois  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Abviva-Announces-Letter-of-Intent-to-Acquire-Prion-Developmental-Laboratories-263700</guid></item><item><title>Abviva, Inc. Announces Investor Conference Call and Webcast</title><link>http://www.finanzen.net/nachricht/aktien/Abviva-Inc-Announces-Investor-Conference-Call-and-Webcast-261890</link><description>Abviva, Inc. (f/k/a Genesis Bioventures, Inc. OTCBB:GBIW) today 
      announced that it has scheduled an investor conference call and webcast 
      to take place on Monday, December 10, 2007 at 4:00 p.m. U.S. EST . Mr. 
      Douglas C. Lane, President  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Abviva-Inc-Announces-Investor-Conference-Call-and-Webcast-261890</guid></item><item><title>Genesis Bioventures Announces Name Change to Abviva, Inc.</title><link>http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-Name-Change-to-Abviva-Inc-261830</link><description>Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that it has 
      completed its planned name change of the corporation to Abviva, Inc.
     
      Genesis Bioventures changed its corporate name to Abviva, Inc. to 
      emphasize its mission  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-Name-Change-to-Abviva-Inc-261830</guid></item><item><title>Genesis Bioventures Letter To Shareholders</title><link>http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Letter-To-Shareholders-223701</link><description>The Company held its 2007 Annual Shareholders Meeting on Wednesday, 
      September 12, 2007. This was the first shareholders meeting the Company 
      has held since 2001. The measures we asked our shareholders to approve 
      were a culmination  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Letter-To-Shareholders-223701</guid></item><item><title>Genesis Bioventures Announces Investor Conference Call and Webcast</title><link>http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-Investor-Conference-Call-and-Webcast-218458</link><description>Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that it has 
      scheduled an investor conference call and webcast to take place on 
      Monday, September 10, 2007 at 4:00 p.m. U.S. ET. Mr. Douglas C. Lane, 
      President and CEO, will  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-Investor-Conference-Call-and-Webcast-218458</guid></item><item><title>Genesis Bioventures Announces Investor Conference Call and Webcast</title><link>http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-Investor-Conference-Call-and-Webcast-211296</link><description>Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that it has 
      scheduled an investor conference call and webcast on Wednesday, August 
      22, 2007 at 4:00 p.m. U.S. EST . Mr. Douglas C. Lane, President and CEO, 
      will discuss  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-Investor-Conference-Call-and-Webcast-211296</guid></item><item><title>Genesis Bioventures, Inc. Announced Today That the Company is Participating in an Audio Interview on Wallst.net on Friday, August 03, 2007</title><link>http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Inc-Announced-Today-That-the-Company-is-Participating-in-an-Audio-Interview-on-Wallst-net-on-Friday-August-03-2007-202848</link><description>Mr. Douglas C. Lane, CEO, stated today that Genesis Bioventures, Inc. 
      were invited to participate in an Audio Interview on Wallst.net 
      scheduled for Friday August 3, 2007 at 8:00 a.m. (PST). Some of the 
      talking points will be an overview  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Inc-Announced-Today-That-the-Company-is-Participating-in-an-Audio-Interview-on-Wallst-net-on-Friday-August-03-2007-202848</guid></item><item><title>Genesis Bioventures Announces Letter of Intent for Sales and Distribution of Mad Cow Test Product in China</title><link>http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-Letter-of-Intent-for-Sales-and-Distribution-of-Mad-Cow-Test-Product-in-China-188600</link><description>Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that 
      BioBDC, the Company’s exclusive agent for 
      sales and distribution of Prion Developmental Laboratories’ 
      (PDL) Rapid BSE assay for Mad Cow testing for the Pacific Rim,  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-Letter-of-Intent-for-Sales-and-Distribution-of-Mad-Cow-Test-Product-in-China-188600</guid></item><item><title>Genesis Bioventures Announces eFund Capital Management, LLC Becomes Active Investor and Financial Consultant for Strategic Development and Financing</title><link>http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-eFund-Capital-Management-LLC-Becomes-Active-Investor-and-Financial-Consultant-for-Strategic-Development-and-Financing-183609</link><description>Genesis Bioventures, Inc. (OTCBB:GBIW) today announced that it entered 
      into an Agreement with eFund Capital Management, LLC (eFund) for 
      corporate financing and strategic development. Under the Agreement eFund 
      will provide additional  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Genesis-Bioventures-Announces-eFund-Capital-Management-LLC-Becomes-Active-Investor-and-Financial-Consultant-for-Strategic-Development-and-Financing-183609</guid></item></channel></rss>

